New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Web-based tool ups informed choice in rheumatoid arthritis

Web-based tool ups informed choice in rheumatoid arthritis

(HealthDay) -- A decision support tool effectively communicates the risks and benefits of biologic therapy to patients with rheumatoid arthritis (RA), increasing their likelihood of making an informed
Arthritis and Rheumatism March 12,2024
Web-based tool ups informed choice in rheumatoid arthritis

Web-based tool ups informed choice in rheumatoid arthritis

(HealthDay) -- A decision support tool effectively communicates the risks and benefits of biologic therapy to patients with rheumatoid arthritis (RA), increasing their likelihood of making an informed
Arthritis and Rheumatism March 12,2024
High doses of triptorelin needed for ovarian suppression in SLE

High doses of triptorelin needed for ovarian suppression in SLE

(HealthDay)—For female patients with childhood-onset systemic lupus erythematosus (SLE) who require treatment with cyclophosphamide, sustained complete ovarian suppression is achieved in 90 percent of
Arthritis and Rheumatism March 11,2024
High doses of triptorelin needed for ovarian suppression in SLE

High doses of triptorelin needed for ovarian suppression in SLE

(HealthDay)—For female patients with childhood-onset systemic lupus erythematosus (SLE) who require treatment with cyclophosphamide, sustained complete ovarian suppression is achieved in 90 percent of
Arthritis and Rheumatism March 11,2024
Sexual function, mental health linked in rheumatic disease

Sexual function, mental health linked in rheumatic disease

(HealthDay)—The presence of anxiety and depression in people with rheumatic diseases may be an independent predictor of sexual dysfunction, according to a study published in the November issue of the&
Arthritis and Rheumatism March 11,2024
Sexual function, mental health linked in rheumatic disease

Sexual function, mental health linked in rheumatic disease

(HealthDay)—The presence of anxiety and depression in people with rheumatic diseases may be an independent predictor of sexual dysfunction, according to a study published in the November issue of the&
Arthritis and Rheumatism March 11,2024
Most part D plans cover at least one biologic DMARD

Most part D plans cover at least one biologic DMARD

(HealthDay)—Although most Medicare Part D plans cover at least one biologic disease-modifying antirheumatic drug (DMARD), copayments are high, according to a study published in the June issue of
Arthritis and Rheumatism March 11,2024
Most part D plans cover at least one biologic DMARD

Most part D plans cover at least one biologic DMARD

(HealthDay)—Although most Medicare Part D plans cover at least one biologic disease-modifying antirheumatic drug (DMARD), copayments are high, according to a study published in the June issue of
Arthritis and Rheumatism March 11,2024
Gout flare-ups rise sharply with certain foods: study

Gout flare-ups rise sharply with certain foods: study

Research found more attacks after high consumption of compounds called purines, especially from meat, seafood.(HealthDay) -- Meat, seafood and other foods rich in compounds called purines are associat
Arthritis and Rheumatism March 11,2024
Gout flare-ups rise sharply with certain foods: study

Gout flare-ups rise sharply with certain foods: study

Research found more attacks after high consumption of compounds called purines, especially from meat, seafood.(HealthDay) -- Meat, seafood and other foods rich in compounds called purines are associat
Arthritis and Rheumatism March 11,2024
ACR: TNF inhibitors linked to reduced risk of ACS in RA

ACR: TNF inhibitors linked to reduced risk of ACS in RA

For patients with rheumatoid arthritis, tumor necrosis factor inhibitor treatment correlates with reductions in the risk of acute coronary syndromes and myocardial infarction, according to two studies
Arthritis and Rheumatism March 11,2024
ACR: TNF inhibitors linked to reduced risk of ACS in RA

ACR: TNF inhibitors linked to reduced risk of ACS in RA

For patients with rheumatoid arthritis, tumor necrosis factor inhibitor treatment correlates with reductions in the risk of acute coronary syndromes and myocardial infarction, according to two studies
Arthritis and Rheumatism March 11,2024
Oral bisphosphonate use cuts risk of post-implant revision Sx

Oral bisphosphonate use cuts risk of post-implant revision Sx

(HealthDay)—For patients undergoing total joint replacement, oral bisphosphonate use is associated with a reduction in the risk of revision surgery, according to a study published in the November issu
Arthritis and Rheumatism March 11,2024
Oral bisphosphonate use cuts risk of post-implant revision Sx

Oral bisphosphonate use cuts risk of post-implant revision Sx

(HealthDay)—For patients undergoing total joint replacement, oral bisphosphonate use is associated with a reduction in the risk of revision surgery, according to a study published in the November issu
Arthritis and Rheumatism March 11,2024
Novel susceptibility loci identified for osteoarthritis

Novel susceptibility loci identified for osteoarthritis

Five novel single nucleotide polymorphisms are significantly associated with osteoarthritis, including one near the nucleostemin-encoding gene, according to a study published online July 3 inThe
Arthritis and Rheumatism March 11,2024
Novel susceptibility loci identified for osteoarthritis

Novel susceptibility loci identified for osteoarthritis

Five novel single nucleotide polymorphisms are significantly associated with osteoarthritis, including one near the nucleostemin-encoding gene, according to a study published online July 3 inThe
Arthritis and Rheumatism March 11,2024
Meta-analysis: Oral contraceptive use not linked to RA onset

Meta-analysis: Oral contraceptive use not linked to RA onset

(HealthDay)—Oral contraceptive (OC) use does not appear to be associated with the risk of rheumatoid arthritis (RA), although there is an inverse association between OC use and RA severity, according
Arthritis and Rheumatism March 11,2024
Meta-analysis: Oral contraceptive use not linked to RA onset

Meta-analysis: Oral contraceptive use not linked to RA onset

(HealthDay)—Oral contraceptive (OC) use does not appear to be associated with the risk of rheumatoid arthritis (RA), although there is an inverse association between OC use and RA severity, according
Arthritis and Rheumatism March 11,2024
Recommendations for managing pain in inflammatory arthritis

Recommendations for managing pain in inflammatory arthritis

(HealthDay)—Recommendations have been developed for the management of pain in adults with optimally treated inflammatory arthritis, according to an article published in the September issue of the&nbsp
Arthritis and Rheumatism March 11,2024
Recommendations for managing pain in inflammatory arthritis

Recommendations for managing pain in inflammatory arthritis

(HealthDay)—Recommendations have been developed for the management of pain in adults with optimally treated inflammatory arthritis, according to an article published in the September issue of the&nbsp
Arthritis and Rheumatism March 11,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com